South Korea's KOSPI index closed at 2,621.33 points on Thursday, May 15, down 19.24 points, or 0.73%.

Important news 1. Foreign institutions upgraded Chinese stock ratings and are optimistic about China's growth prospects. 2. Goldman Sachs: Maintains overweight rating for Chinese stocks and recommends focusing on multiple main lines to capture thematic excess returns. 3. China Securities Regulatory Commission: Focus on combating insider trading, market manipulation, and other illegal activities that seriously infringe on the interests of small and medium-sized investors. 4. China Securities Regulatory Commission: Speed up the introduction of a package of policy measures to deepen the reform of the Science and Technology Innovation Board and the Growth Enterprise Market, and effectively promote the increase in the scale and proportion of medium- and long-term funds entering the market. 5. Rare earth good news frequently, high valuations still need to be further digested. 6. Foreign trade companies restart supply to the US market, and container space on US routes is hard to find. Stock news 1. The data of main capital flow shows that the net inflow of main capital of Chuan Ning Biotechnology is 552 million yuan, ranking first, Shenghe Resources, Prince New Materials, Tongda Shares, and BYD have received the largest net inflow of main capital; the net outflow of main capital of Oriental Fortune is 1.016 billion yuan, ranking first, and the net outflow of main capital of Tuowei Information, Luxshare Precision, Hainan Huatie, and Zhongyida has the largest net outflow. 2. Xinkaiyuan: It is expected that the shipment volume of PVP in the new energy field will still increase year-on-year this year. 3. Staff of the Secretary's Office of Tianyin Holdings: No price reduction notice has been received so far, and Apple usually does not issue the so-called official price reduction notice. 4. Sinopharm Group: Guangzhou Guojian Capital Management Co., Ltd. and its affiliated companies have never been authorized to carry out project investment or cooperation publicity in the name of "Sinopharm Group member enterprises".

BlackRock CEO: Tariffs are disruptive, but the risk is not systemic.